Victoria Socha

DocwireNews

The most common monogenic nephropathy is autosomal dominant polycystic kidney disease (ADPKD). ADPKD is associated with variability in severity of kidney disease among affected relatives and families. Researchers in Ireland, led by Elhussein A. E. Elhassan, MD, conducted an analysis to examine variation in phenotype between families of adult Irish patients affected by ADPKD and assess the impact of kinship on disease progression.Results were reported during a poster session at the American Society of Nephrology Kidney Week 2022 in a poster titled Effects of Kinship on Disease Progression and Variability in Families With Autosomal Dominant Polycystic Kidney Disease.The researchers collected data on phenotype (age, sex, kinship with index patient, age at initial presentation, hypertension and urological events, and Predicting Renal Outcomes in Polycystic Kidney Disease score), as well as renal survival (time to end-stage renal disease [ESRD] and decline in estimated glomerular filtration rate [eGFR]). Patients with disease-causing PKD1 and PKD2 variants were included in the analysis. ADPKD was diagnosed using a combination of molecular methods, including targeted next-generation sequencing.Variability between families was assessed based on the age at onset of ESRD. A frailty model using detailed phenotypic features of patients with available genetic diagnosis was used to account for the impact of kinship on disease progression.The analysis included data on 103 unrelated families (369 patients). A majority (63.1%, n=65) had a diagnostic variant at PKD1 gene. Average age was 55.2 years, and 55.3% were female. Mean age at initial presentation was 30.2 years. At last follow-up, 71% of the patients (n=262) developed ESRD. The remaining patients had chronic kidney disease, with average creatinine 133.2 mg/dL and average eGFR 51.2 mL/min/1.73 m2. Mean annual eGFR decline was 3.1 mL/min/1.73 m2 per year.Median variance in age at time of ESRD between families was 7 years. Among families with at least two ESRD patients, 33% (n=34) of families had wide delta difference in age at ESRD (eg, &gt;10 years difference).In the univariate frailty model, there was a significant association between kinship and time to renal failure (P&lt;.001), taking into account phenotypic and genetic factors that are associated with disease severity. In multivariate analyses, there was no statistical impact of kinship in age at ESRD, with the exception of those with earlier initial presentation (hazard ratio, 0.96; 95% CI, 0.94-0.98; P&lt;.001).&ldquo;Wide variability in age of ESRD among families with ADPKD is present in at least 33% of families, and the impact of family effects was evident on factors related with disease progression,&rdquo; the researchers said.Source: Elhassan EAE, Collins KE, Gilbert EH, Cavalleri G, Benson KA, Conlon PJ. Effects of kinship on disease progression and variability in families with autosomal dominant polycystic kidney disease. TH-PO364. Abstract of a poster presented at the American Society of Nephrology Kidney Week 2022; November 3, 2022; Orlando, Florida.

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Disease Progression and Variability of ADPKD

ASN Kidney Week 2022

The most common monogenic nephropathy is autosomal dominant polycystic kidney disease (ADPKD). ADPKD is associated with variability in severity of kidney disease among ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe